Risk stratification in patients with hypertrophic cardiomyopathy: Looking beyond the left side myocardial function

Hao-Chih Chang1,2, Hao-Min Cheng3,4,5,6, Ling Kuo2,5,7

  • 1Department of Medicine, Taipei Veterans General Hospital Yuanshan and Suao Branch, Yilan, Taiwan, ROC.

Insights

Right ventricular (RV) function, measured by tricuspid annular plane systolic excursion (TAPSE) and RV free wall strain, predicts cardiac events in hypertrophic cardiomyopathy (HCM) patients. This highlights the importance of assessing RV function for improved risk stratification.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Cardiac Electrophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by heterogeneous patient outcomes.
  • Current risk stratification primarily focuses on left ventricular (LV) function.
  • The prognostic significance of right ventricular (RV) function in HCM remains under-investigated.

Purpose of the Study:

  • To investigate the prognostic value of right ventricular (RV) function in patients with hypertrophic cardiomyopathy (HCM).
  • To determine if RV functional parameters improve risk stratification beyond traditional LV measures.

Main Methods:

  • Retrospective cohort study of 56 HCM patients.
  • Assessment of conventional parameters (LVEF, TAPSE) and RV free wall strain via speckle tracking.
  • Primary endpoint: composite of heart failure hospitalization, sustained ventricular tachycardia, or all-cause death.

Main Results:

  • RV free wall strain and TAPSE were impaired in patients with cardiovascular events.
  • TAPSE and RV free wall strain were independent predictors of adverse outcomes after adjusting for LVEF.
  • Incorporating RV parameters (TAPSE or RV free wall strain) significantly improved risk reclassification compared to LV strain alone.

Conclusions:

  • Right ventricular (RV) function, assessed by TAPSE or RV free wall strain, is a significant predictor of cardiac events in HCM.
  • Comprehensive evaluation of RV function is valuable for enhancing risk stratification in HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
34